サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1428654

接触式ランセットの世界市場に関する洞察、2030年までの予測

Global Contact-Activated Lancet Market Insights, Forecast to 2030
出版日: | 発行: QYResearch | ページ情報: 英文 106 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
接触式ランセットの世界市場に関する洞察、2030年までの予測
出版日: 2024年02月21日
発行: QYResearch
ページ情報: 英文 106 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、接触式ランセット (Contact-Activated Lancet) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 接触式ランセットの製品概要
  • 市場：タイプ別
    • 世界の接触式ランセットの市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
    • Below 30G
    • Above 30G
  • 市場：用途別
    • 世界の接触式ランセットの市場規模成長率：用途別, 2019 VS 2023 VS 2030
    • Hospital
    • Clinic
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の接触式ランセット 売上予測・予想 2019-2030
  • 世界の接触式ランセットの収益：地域別
    • 世界の接触式ランセットの収益：地域別: 2019 VS 2023 VS 2030
    • 世界の接触式ランセットの収益：地域別 (2019-2024)
    • 世界の接触式ランセットの収益：地域別 (2025-2030)
    • 世界の接触式ランセットの収益市場シェア 地域別 (2019-2030)
  • 世界の接触式ランセット 売上予測・予想 2019-2030
  • 世界の接触式ランセットの販売：地域別
    • 世界の接触式ランセットの販売：地域別: 2019 VS 2023 VS 2030
    • 世界の接触式ランセットの販売：地域別 (2019-2024)
    • 世界の接触式ランセットの販売：地域別 (2025-2030)
    • 世界の接触式ランセットの販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の接触式ランセットの販売：企業別
    • 世界の接触式ランセットの販売：企業別 (2019-2024)
    • 世界の接触式ランセットの販売市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： 接触式ランセット in 2023
  • 世界の接触式ランセットの収益：企業別
    • 世界の接触式ランセットの収益：企業別 (2019-2024)
    • 世界の接触式ランセットの収益市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： 接触式ランセットの収益 2023
  • 世界の主要企業 接触式ランセット, 業界ランキング, 2022 VS 2023 VS 2024
  • 世界の接触式ランセットの販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の接触式ランセットの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 接触式ランセット, 製造拠点分布と本社
  • 世界の主要メーカー 接触式ランセット, 提供製品と用途
  • 世界の主要メーカー 接触式ランセット, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の接触式ランセットの販売：タイプ別
    • 世界の接触式ランセットの販売実績：タイプ別 (2019-2024)
    • 世界の接触式ランセットの販売予測：タイプ別 (2025-2030)
    • 世界の接触式ランセットの販売市場シェア：タイプ別 (2019-2030)
  • 世界の接触式ランセット 収益：タイプ別
    • 世界の接触式ランセットの収益実績：タイプ別 (2019-2024)
    • 世界の接触式ランセットの収益予測：タイプ別 (2025-2030)
    • 世界の接触式ランセットの収益市場シェア：タイプ別 (2019-2030)
  • 世界の接触式ランセットの価格：タイプ別
    • 世界の接触式ランセットの価格：タイプ別 (2019-2024)
    • 世界の接触式ランセットの価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

  • 世界の接触式ランセットの販売：用途別
    • 世界の接触式ランセットの販売実績：用途別 (2019-2024)
    • 世界の接触式ランセットの販売予測：用途別 (2025-2030)
    • 世界の接触式ランセットの販売市場シェア：用途別 (2019-2030)
  • 世界の接触式ランセットの収益：用途別
    • 世界の接触式ランセットの収益実績：用途別 (2019-2024)
    • 世界の接触式ランセットの収益予測：用途別 (2025-2030)
    • 世界の接触式ランセットの収益市場シェア：用途別 (2019-2030)
  • 世界の接触式ランセットの価格：用途別
    • 世界の接触式ランセットの価格：用途別 (2019-2024)
    • 世界の接触式ランセットの価格予測：用途別 (2025-2030)

第6章 米国・カナダ

  • 米国・カナダ 接触式ランセット 市場規模：タイプ別
    • 米国・カナダ 接触式ランセットの販売：タイプ別 (2019-2030)
    • 米国・カナダ 接触式ランセット 収益：タイプ別 (2019-2030)
  • 米国・カナダ 接触式ランセット 市場規模：用途別
    • 米国・カナダ 接触式ランセットの販売：用途別 (2019-2030)
    • 米国・カナダ 接触式ランセットの収益：用途別 (2019-2030)
  • 米国・カナダ 接触式ランセット 市場規模：国別
    • 米国・カナダ 接触式ランセットの収益：国別: 2019 VS 2023 VS 2030
    • 米国・カナダ 接触式ランセットの販売：国別 (2019-2030)
    • 米国・カナダ 接触式ランセットの収益：国別 (2019-2030)
    • US
    • カナダ

第7章 欧州

  • 欧州の接触式ランセット 市場規模：タイプ別
    • 欧州の接触式ランセットの販売：タイプ別 (2019-2030)
    • 欧州の接触式ランセット 収益：タイプ別 (2019-2030)
  • 欧州の接触式ランセット 市場規模：用途別
    • 欧州の接触式ランセットの販売：用途別 (2019-2030)
    • 欧州の接触式ランセットの収益：用途別 (2019-2030)
  • 欧州の接触式ランセット 市場規模：国別
    • 欧州の接触式ランセットの収益：国別: 2019 VS 2023 VS 2030
    • 欧州の接触式ランセットの販売：国別 (2019-2030)
    • 欧州の接触式ランセットの収益：国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • オランダ

第8章 中国

  • 中国の接触式ランセット 市場規模
    • 中国の接触式ランセット 売上 (2019-2030)
    • 中国の接触式ランセット 収益 (2019-2030)
  • 中国の接触式ランセット 市場規模：用途別
    • 中国の接触式ランセットの販売：用途別 (2019-2030)
    • 中国の接触式ランセットの収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

  • アジア地域 接触式ランセット 市場規模：タイプ別
    • アジア地域 接触式ランセットの販売：タイプ別 (2019-2030)
    • アジア地域 接触式ランセット 収益：タイプ別 (2019-2030)
  • アジア地域 接触式ランセット 市場規模：用途別
    • アジア地域 接触式ランセットの販売：用途別 (2019-2030)
    • アジア地域 接触式ランセットの収益：用途別 (2019-2030)
  • アジア地域 接触式ランセットの販売：地域別
    • アジア地域 接触式ランセットの収益：地域別: 2019 VS 2023 VS 2030
    • アジア地域 接触式ランセットの収益：地域別 (2019-2030)
    • アジア地域 接触式ランセットの販売：地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの接触式ランセット 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの接触式ランセットの販売：タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの接触式ランセット 収益：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの接触式ランセット 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの接触式ランセットの販売：用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの接触式ランセットの収益：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの接触式ランセットの販売：国別
    • 中東, アフリカ ・ラテンアメリカの接触式ランセットの収益：国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカの接触式ランセットの収益：国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの接触式ランセットの販売：国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • BD
  • Accu-Chek (Roche)
  • OneTouch (LifeScan)
  • FreeStyle (Abbott)
  • Microlet Next (Ascensia)
  • Terumo
  • Genteel
  • CareTouch
  • Pip Diabetes Care
  • Owen Mumford
  • Trividia Health
  • AUVON

第12章 業界チェーンと販売チャネルの分析

  • 接触式ランセット 業界チェーン分析
  • 接触式ランセット 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 接触式ランセット 生産形態とプロセス
  • 接触式ランセット 販売およびマーケティング
    • 接触式ランセット 販売チャネルs
    • 接触式ランセット 卸業者
  • 接触式ランセット 顧客

第13章 市場動向

  • 接触式ランセット 業界動向
  • 接触式ランセット 市場の促進要因
  • 接触式ランセット 市場の課題
  • 接触式ランセット 市場の抑制要因

第14章 主な調査結果 世界の接触式ランセットの主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Contact-Activated Lancet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of Below 30G
  • Table 3. Major Manufacturers of Above 30G
  • Table 4. Global Contact-Activated Lancet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 5. Global Contact-Activated Lancet Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 6. Global Contact-Activated Lancet Revenue by Region (2019-2024) & (US$ Million)
  • Table 7. Global Contact-Activated Lancet Revenue by Region (2025-2030) & (US$ Million)
  • Table 8. Global Contact-Activated Lancet Revenue Market Share by Region (2019-2024)
  • Table 9. Global Contact-Activated Lancet Revenue Market Share by Region (2025-2030)
  • Table 10. Global Contact-Activated Lancet Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 11. Global Contact-Activated Lancet Sales by Region (2019-2024) & (K Units)
  • Table 12. Global Contact-Activated Lancet Sales by Region (2025-2030) & (K Units)
  • Table 13. Global Contact-Activated Lancet Sales Market Share by Region (2019-2024)
  • Table 14. Global Contact-Activated Lancet Sales Market Share by Region (2025-2030)
  • Table 15. Global Contact-Activated Lancet Sales by Manufacturers (2019-2024) & (K Units)
  • Table 16. Global Contact-Activated Lancet Sales Share by Manufacturers (2019-2024)
  • Table 17. Global Contact-Activated Lancet Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 18. Global Contact-Activated Lancet Revenue Share by Manufacturers (2019-2024)
  • Table 19. Global Key Players of Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 20. Contact-Activated Lancet Price by Manufacturers 2019-2024 (US$/Unit)
  • Table 21. Global Contact-Activated Lancet Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Contact-Activated Lancet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contact-Activated Lancet as of 2023)
  • Table 23. Global Key Manufacturers of Contact-Activated Lancet, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Contact-Activated Lancet, Product Offered and Application
  • Table 25. Global Key Manufacturers of Contact-Activated Lancet, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
  • Table 28. Global Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
  • Table 29. Global Contact-Activated Lancet Sales Share by Type (2019-2024)
  • Table 30. Global Contact-Activated Lancet Sales Share by Type (2025-2030)
  • Table 31. Global Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
  • Table 32. Global Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
  • Table 33. Global Contact-Activated Lancet Revenue Share by Type (2019-2024)
  • Table 34. Global Contact-Activated Lancet Revenue Share by Type (2025-2030)
  • Table 35. Contact-Activated Lancet Price by Type (2019-2024) & (US$/Unit)
  • Table 36. Global Contact-Activated Lancet Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 37. Global Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
  • Table 38. Global Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
  • Table 39. Global Contact-Activated Lancet Sales Share by Application (2019-2024)
  • Table 40. Global Contact-Activated Lancet Sales Share by Application (2025-2030)
  • Table 41. Global Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
  • Table 42. Global Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
  • Table 43. Global Contact-Activated Lancet Revenue Share by Application (2019-2024)
  • Table 44. Global Contact-Activated Lancet Revenue Share by Application (2025-2030)
  • Table 45. Contact-Activated Lancet Price by Application (2019-2024) & (US$/Unit)
  • Table 46. Global Contact-Activated Lancet Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 47. US & Canada Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
  • Table 48. US & Canada Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
  • Table 49. US & Canada Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
  • Table 50. US & Canada Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
  • Table 51. US & Canada Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
  • Table 52. US & Canada Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
  • Table 53. US & Canada Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
  • Table 54. US & Canada Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
  • Table 55. US & Canada Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 56. US & Canada Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
  • Table 57. US & Canada Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
  • Table 58. US & Canada Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
  • Table 59. US & Canada Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
  • Table 60. Europe Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
  • Table 61. Europe Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
  • Table 62. Europe Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
  • Table 63. Europe Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
  • Table 64. Europe Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
  • Table 65. Europe Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
  • Table 66. Europe Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
  • Table 67. Europe Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
  • Table 68. Europe Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 69. Europe Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
  • Table 70. Europe Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
  • Table 71. Europe Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
  • Table 72. Europe Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
  • Table 73. China Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
  • Table 74. China Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
  • Table 75. China Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
  • Table 76. China Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
  • Table 77. China Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
  • Table 78. China Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
  • Table 79. China Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
  • Table 80. China Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
  • Table 81. Asia Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
  • Table 82. Asia Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
  • Table 83. Asia Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
  • Table 84. Asia Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
  • Table 85. Asia Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
  • Table 86. Asia Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
  • Table 87. Asia Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
  • Table 88. Asia Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
  • Table 89. Asia Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 90. Asia Contact-Activated Lancet Revenue by Region (2019-2024) & (US$ Million)
  • Table 91. Asia Contact-Activated Lancet Revenue by Region (2025-2030) & (US$ Million)
  • Table 92. Asia Contact-Activated Lancet Sales by Region (2019-2024) & (K Units)
  • Table 93. Asia Contact-Activated Lancet Sales by Region (2025-2030) & (K Units)
  • Table 94. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
  • Table 95. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
  • Table 96. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
  • Table 99. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
  • Table 100. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
  • Table 106. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
  • Table 107. BD Company Information
  • Table 108. BD Description and Major Businesses
  • Table 109. BD Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 110. BD Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. BD Recent Developments
  • Table 112. Accu-Chek (Roche) Company Information
  • Table 113. Accu-Chek (Roche) Description and Major Businesses
  • Table 114. Accu-Chek (Roche) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 115. Accu-Chek (Roche) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Accu-Chek (Roche) Recent Developments
  • Table 117. OneTouch (LifeScan) Company Information
  • Table 118. OneTouch (LifeScan) Description and Major Businesses
  • Table 119. OneTouch (LifeScan) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 120. OneTouch (LifeScan) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. OneTouch (LifeScan) Recent Developments
  • Table 122. FreeStyle (Abbott) Company Information
  • Table 123. FreeStyle (Abbott) Description and Major Businesses
  • Table 124. FreeStyle (Abbott) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 125. FreeStyle (Abbott) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. FreeStyle (Abbott) Recent Developments
  • Table 127. Microlet Next (Ascensia) Company Information
  • Table 128. Microlet Next (Ascensia) Description and Major Businesses
  • Table 129. Microlet Next (Ascensia) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 130. Microlet Next (Ascensia) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Microlet Next (Ascensia) Recent Developments
  • Table 132. Terumo Company Information
  • Table 133. Terumo Description and Major Businesses
  • Table 134. Terumo Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 135. Terumo Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Terumo Recent Developments
  • Table 137. Genteel Company Information
  • Table 138. Genteel Description and Major Businesses
  • Table 139. Genteel Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 140. Genteel Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Genteel Recent Developments
  • Table 142. CareTouch Company Information
  • Table 143. CareTouch Description and Major Businesses
  • Table 144. CareTouch Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 145. CareTouch Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. CareTouch Recent Developments
  • Table 147. Pip Diabetes Care Company Information
  • Table 148. Pip Diabetes Care Description and Major Businesses
  • Table 149. Pip Diabetes Care Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 150. Pip Diabetes Care Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Pip Diabetes Care Recent Developments
  • Table 152. Owen Mumford Company Information
  • Table 153. Owen Mumford Description and Major Businesses
  • Table 154. Owen Mumford Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 155. Owen Mumford Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Owen Mumford Recent Developments
  • Table 157. Trividia Health Company Information
  • Table 158. Trividia Health Description and Major Businesses
  • Table 159. Trividia Health Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 160. Trividia Health Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. Trividia Health Recent Developments
  • Table 162. AUVON Company Information
  • Table 163. AUVON Description and Major Businesses
  • Table 164. AUVON Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 165. AUVON Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 166. AUVON Recent Developments
  • Table 167. Key Raw Materials Lists
  • Table 168. Raw Materials Key Suppliers Lists
  • Table 169. Contact-Activated Lancet Distributors List
  • Table 170. Contact-Activated Lancet Customers List
  • Table 171. Contact-Activated Lancet Market Trends
  • Table 172. Contact-Activated Lancet Market Drivers
  • Table 173. Contact-Activated Lancet Market Challenges
  • Table 174. Contact-Activated Lancet Market Restraints
  • Table 175. Research Programs/Design for This Report
  • Table 176. Key Data Information from Secondary Sources
  • Table 177. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Contact-Activated Lancet Product Picture
  • Figure 2. Global Contact-Activated Lancet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Contact-Activated Lancet Market Share by Type in 2023 & 2030
  • Figure 4. Below 30G Product Picture
  • Figure 5. Above 30G Product Picture
  • Figure 6. Global Contact-Activated Lancet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 7. Global Contact-Activated Lancet Market Share by Application in 2023 & 2030
  • Figure 8. Hospital
  • Figure 9. Clinic
  • Figure 10. Others
  • Figure 11. Contact-Activated Lancet Report Years Considered
  • Figure 12. Global Contact-Activated Lancet Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 13. Global Contact-Activated Lancet Revenue 2019-2030 (US$ Million)
  • Figure 14. Global Contact-Activated Lancet Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 15. Global Contact-Activated Lancet Revenue Market Share by Region (2019-2030)
  • Figure 16. Global Contact-Activated Lancet Sales 2019-2030 ((K Units)
  • Figure 17. Global Contact-Activated Lancet Sales Market Share by Region (2019-2030)
  • Figure 18. US & Canada Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
  • Figure 19. US & Canada Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
  • Figure 20. Europe Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
  • Figure 21. Europe Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
  • Figure 22. China Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
  • Figure 23. China Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
  • Figure 24. Asia (excluding China) Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
  • Figure 25. Asia (excluding China) Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
  • Figure 26. Middle East, Africa and Latin America Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
  • Figure 27. Middle East, Africa and Latin America Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
  • Figure 28. The Contact-Activated Lancet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Contact-Activated Lancet in the World: Market Share by Contact-Activated Lancet Revenue in 2023
  • Figure 30. Global Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 31. Global Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • Figure 32. Global Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • Figure 33. Global Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • Figure 34. Global Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • Figure 35. US & Canada Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • Figure 36. US & Canada Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • Figure 37. US & Canada Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • Figure 38. US & Canada Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • Figure 39. US & Canada Contact-Activated Lancet Revenue Share by Country (2019-2030)
  • Figure 40. US & Canada Contact-Activated Lancet Sales Share by Country (2019-2030)
  • Figure 41. U.S. Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 42. Canada Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 43. Europe Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • Figure 44. Europe Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • Figure 45. Europe Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • Figure 46. Europe Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • Figure 47. Europe Contact-Activated Lancet Revenue Share by Country (2019-2030)
  • Figure 48. Europe Contact-Activated Lancet Sales Share by Country (2019-2030)
  • Figure 49. Germany Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 50. France Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 51. U.K. Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 52. Italy Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 53. Netherlands Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 54. China Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • Figure 55. China Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • Figure 56. China Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • Figure 57. China Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • Figure 58. Asia Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • Figure 59. Asia Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • Figure 60. Asia Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • Figure 61. Asia Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • Figure 62. Asia Contact-Activated Lancet Revenue Share by Region (2019-2030)
  • Figure 63. Asia Contact-Activated Lancet Sales Share by Region (2019-2030)
  • Figure 64. Japan Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 65. South Korea Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 66. China Taiwan Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 67. Southeast Asia Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 68. India Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • Figure 70. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • Figure 71. Middle East, Africa and Latin America Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • Figure 72. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • Figure 73. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Share by Country (2019-2030)
  • Figure 74. Middle East, Africa and Latin America Contact-Activated Lancet Sales Share by Country (2019-2030)
  • Figure 75. Brazil Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 76. Mexico Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 77. Turkey Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 78. Israel Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 79. GCC Countries Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
  • Figure 80. Contact-Activated Lancet Value Chain
  • Figure 81. Contact-Activated Lancet Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the Contact-Activated Lancet Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Contact-Activated Lancet Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Contact-Activated Lancet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Below 30G
    • 1.2.3 Above 30G
  • 1.3 Market by Application
    • 1.3.1 Global Contact-Activated Lancet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Contact-Activated Lancet Sales Estimates and Forecasts 2019-2030
  • 2.2 Global Contact-Activated Lancet Revenue by Region
    • 2.2.1 Global Contact-Activated Lancet Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Contact-Activated Lancet Revenue by Region (2019-2024)
    • 2.2.3 Global Contact-Activated Lancet Revenue by Region (2025-2030)
    • 2.2.4 Global Contact-Activated Lancet Revenue Market Share by Region (2019-2030)
  • 2.3 Global Contact-Activated Lancet Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Contact-Activated Lancet Sales by Region
    • 2.4.1 Global Contact-Activated Lancet Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Contact-Activated Lancet Sales by Region (2019-2024)
    • 2.4.3 Global Contact-Activated Lancet Sales by Region (2025-2030)
    • 2.4.4 Global Contact-Activated Lancet Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Contact-Activated Lancet Sales by Manufacturers
    • 3.1.1 Global Contact-Activated Lancet Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Contact-Activated Lancet Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contact-Activated Lancet in 2023
  • 3.2 Global Contact-Activated Lancet Revenue by Manufacturers
    • 3.2.1 Global Contact-Activated Lancet Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Contact-Activated Lancet Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Contact-Activated Lancet Revenue in 2023
  • 3.3 Global Key Players of Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
  • 3.4 Global Contact-Activated Lancet Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Contact-Activated Lancet, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Contact-Activated Lancet, Product Offered and Application
  • 3.8 Global Key Manufacturers of Contact-Activated Lancet, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Contact-Activated Lancet Sales by Type
    • 4.1.1 Global Contact-Activated Lancet Historical Sales by Type (2019-2024)
    • 4.1.2 Global Contact-Activated Lancet Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Contact-Activated Lancet Sales Market Share by Type (2019-2030)
  • 4.2 Global Contact-Activated Lancet Revenue by Type
    • 4.2.1 Global Contact-Activated Lancet Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Contact-Activated Lancet Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
  • 4.3 Global Contact-Activated Lancet Price by Type
    • 4.3.1 Global Contact-Activated Lancet Price by Type (2019-2024)
    • 4.3.2 Global Contact-Activated Lancet Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Contact-Activated Lancet Sales by Application
    • 5.1.1 Global Contact-Activated Lancet Historical Sales by Application (2019-2024)
    • 5.1.2 Global Contact-Activated Lancet Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Contact-Activated Lancet Sales Market Share by Application (2019-2030)
  • 5.2 Global Contact-Activated Lancet Revenue by Application
    • 5.2.1 Global Contact-Activated Lancet Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Contact-Activated Lancet Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
  • 5.3 Global Contact-Activated Lancet Price by Application
    • 5.3.1 Global Contact-Activated Lancet Price by Application (2019-2024)
    • 5.3.2 Global Contact-Activated Lancet Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Contact-Activated Lancet Market Size by Type
    • 6.1.1 US & Canada Contact-Activated Lancet Sales by Type (2019-2030)
    • 6.1.2 US & Canada Contact-Activated Lancet Revenue by Type (2019-2030)
  • 6.2 US & Canada Contact-Activated Lancet Market Size by Application
    • 6.2.1 US & Canada Contact-Activated Lancet Sales by Application (2019-2030)
    • 6.2.2 US & Canada Contact-Activated Lancet Revenue by Application (2019-2030)
  • 6.3 US & Canada Contact-Activated Lancet Market Size by Country
    • 6.3.1 US & Canada Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Contact-Activated Lancet Sales by Country (2019-2030)
    • 6.3.3 US & Canada Contact-Activated Lancet Revenue by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Contact-Activated Lancet Market Size by Type
    • 7.1.1 Europe Contact-Activated Lancet Sales by Type (2019-2030)
    • 7.1.2 Europe Contact-Activated Lancet Revenue by Type (2019-2030)
  • 7.2 Europe Contact-Activated Lancet Market Size by Application
    • 7.2.1 Europe Contact-Activated Lancet Sales by Application (2019-2030)
    • 7.2.2 Europe Contact-Activated Lancet Revenue by Application (2019-2030)
  • 7.3 Europe Contact-Activated Lancet Market Size by Country
    • 7.3.1 Europe Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Contact-Activated Lancet Sales by Country (2019-2030)
    • 7.3.3 Europe Contact-Activated Lancet Revenue by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Netherlands

8 China

  • 8.1 China Contact-Activated Lancet Market Size
    • 8.1.1 China Contact-Activated Lancet Sales (2019-2030)
    • 8.1.2 China Contact-Activated Lancet Revenue (2019-2030)
  • 8.2 China Contact-Activated Lancet Market Size by Application
    • 8.2.1 China Contact-Activated Lancet Sales by Application (2019-2030)
    • 8.2.2 China Contact-Activated Lancet Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Contact-Activated Lancet Market Size by Type
    • 9.1.1 Asia Contact-Activated Lancet Sales by Type (2019-2030)
    • 9.1.2 Asia Contact-Activated Lancet Revenue by Type (2019-2030)
  • 9.2 Asia Contact-Activated Lancet Market Size by Application
    • 9.2.1 Asia Contact-Activated Lancet Sales by Application (2019-2030)
    • 9.2.2 Asia Contact-Activated Lancet Revenue by Application (2019-2030)
  • 9.3 Asia Contact-Activated Lancet Sales by Region
    • 9.3.1 Asia Contact-Activated Lancet Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Contact-Activated Lancet Revenue by Region (2019-2030)
    • 9.3.3 Asia Contact-Activated Lancet Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Contact-Activated Lancet Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Contact-Activated Lancet Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 BD
    • 11.1.1 BD Company Information
    • 11.1.2 BD Overview
    • 11.1.3 BD Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 BD Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 BD Recent Developments
  • 11.2 Accu-Chek (Roche)
    • 11.2.1 Accu-Chek (Roche) Company Information
    • 11.2.2 Accu-Chek (Roche) Overview
    • 11.2.3 Accu-Chek (Roche) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Accu-Chek (Roche) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Accu-Chek (Roche) Recent Developments
  • 11.3 OneTouch (LifeScan)
    • 11.3.1 OneTouch (LifeScan) Company Information
    • 11.3.2 OneTouch (LifeScan) Overview
    • 11.3.3 OneTouch (LifeScan) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 OneTouch (LifeScan) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 OneTouch (LifeScan) Recent Developments
  • 11.4 FreeStyle (Abbott)
    • 11.4.1 FreeStyle (Abbott) Company Information
    • 11.4.2 FreeStyle (Abbott) Overview
    • 11.4.3 FreeStyle (Abbott) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 FreeStyle (Abbott) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 FreeStyle (Abbott) Recent Developments
  • 11.5 Microlet Next (Ascensia)
    • 11.5.1 Microlet Next (Ascensia) Company Information
    • 11.5.2 Microlet Next (Ascensia) Overview
    • 11.5.3 Microlet Next (Ascensia) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.5.4 Microlet Next (Ascensia) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Microlet Next (Ascensia) Recent Developments
  • 11.6 Terumo
    • 11.6.1 Terumo Company Information
    • 11.6.2 Terumo Overview
    • 11.6.3 Terumo Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.6.4 Terumo Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Terumo Recent Developments
  • 11.7 Genteel
    • 11.7.1 Genteel Company Information
    • 11.7.2 Genteel Overview
    • 11.7.3 Genteel Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.7.4 Genteel Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Genteel Recent Developments
  • 11.8 CareTouch
    • 11.8.1 CareTouch Company Information
    • 11.8.2 CareTouch Overview
    • 11.8.3 CareTouch Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.8.4 CareTouch Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 CareTouch Recent Developments
  • 11.9 Pip Diabetes Care
    • 11.9.1 Pip Diabetes Care Company Information
    • 11.9.2 Pip Diabetes Care Overview
    • 11.9.3 Pip Diabetes Care Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.9.4 Pip Diabetes Care Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Pip Diabetes Care Recent Developments
  • 11.10 Owen Mumford
    • 11.10.1 Owen Mumford Company Information
    • 11.10.2 Owen Mumford Overview
    • 11.10.3 Owen Mumford Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.10.4 Owen Mumford Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Owen Mumford Recent Developments
  • 11.11 Trividia Health
    • 11.11.1 Trividia Health Company Information
    • 11.11.2 Trividia Health Overview
    • 11.11.3 Trividia Health Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.11.4 Trividia Health Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Trividia Health Recent Developments
  • 11.12 AUVON
    • 11.12.1 AUVON Company Information
    • 11.12.2 AUVON Overview
    • 11.12.3 AUVON Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.12.4 AUVON Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 AUVON Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Contact-Activated Lancet Industry Chain Analysis
  • 12.2 Contact-Activated Lancet Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Contact-Activated Lancet Production Mode & Process
  • 12.4 Contact-Activated Lancet Sales and Marketing
    • 12.4.1 Contact-Activated Lancet Sales Channels
    • 12.4.2 Contact-Activated Lancet Distributors
  • 12.5 Contact-Activated Lancet Customers

13 Market Dynamics

  • 13.1 Contact-Activated Lancet Industry Trends
  • 13.2 Contact-Activated Lancet Market Drivers
  • 13.3 Contact-Activated Lancet Market Challenges
  • 13.4 Contact-Activated Lancet Market Restraints

14 Key Findings in The Global Contact-Activated Lancet Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer